• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Examination of the mechanism of the transition to isolated diastolic heart failure

Research Project

Project/Area Number 10670653
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionOsaka University

Principal Investigator

MASUYAMA Tohru  Osaka University Graduate School of Medicine, Assistant Professor, 医学系研究科, 助手 (70273670)

Co-Investigator(Kenkyū-buntansha) DOI Reiko  Osaka University Hospital, Medical Staff, 医学部・附属病院, 医員
YAMAMOTO Kazuhiro  Osaka University Graduate School of Medicine, Assistant Professor, 医学系研究科, 助手 (90303966)
HORI Masatsugu  Osaka University Graduate School of Medicine, Professor, 医学系研究科, 教授 (20124779)
MIWA Takeshi  Osaka University, Genome Information Research Center, Associate Professor, 遺伝情報実験施設, 助教授 (20174229)
近藤 寛也  大阪大学, 医学部, リサーチアソシエイト (40294102)
Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥3,200,000 (Direct Cost: ¥3,200,000)
Fiscal Year 1999: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1998: ¥2,400,000 (Direct Cost: ¥2,400,000)
Keywordsisolated diastolic heart failure / hypertension / hypertrophy / fibrosis / renin-angiotensin system
Research Abstract

In spite of frequent occurrence of isolated diastolic heart failure with preserved systolic function, our understanding of its pathophysiology is limited because an animal model for isolated diastolic heart failure has not been established. We have demonstrated that Dahl-Iwai salt-sensitive (Dahl-S) rats fed on high salt diet from 7 weeks old develop hypertension followed by compensated LV hypertrophy (LVH) at 13 weeks and isolated diastolic heart failure at 19 weeks. At the failing stage in this model (19 weeks), progressive fibrosis and an increase in LV ACE mRNA were observed. We further studied whether the local renin-angiotensin system (RAS) was associated with transition to isolated diastolic heart failure by studying effects of chronic administration Angiotensin II type 1 receptor (AT1-R) antagonist (Candesartan Cilexetil) on LV geometry and function. Dahl-S rats were placed on high salt diet with or without oral administration Candesartan Cilexetil (1mg/kg/day). An increase in the LV mass/weight in the treated rats at 13 weeks was comparable to that in the untreated rats, but a further increase thereafter was observed only in the untreated rats. At 19 weeks, the elevation of LVEDP and myocardial fibrosis were observed in the untreated rats, and Candesartan Cilexetil prevented these changes. Thus, AT1-R antagonist Candesartan Cilexetil did not restrain initial adaptive LVH up to compensated stage, but prevented non-adaptive excessive LVH thereafter and myocardial fibrosis, which benefited in stopping or at least in delaying the transition to decompensation. In conclusion, cardiac RAS seems to play an important role in facilitating excessive LV hypertrophy and myocardial fibrosis that closely link to isolated diastolic heart failure.

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (24 results)

All Other

All Publications (24 results)

  • [Publications] Doi R et al.: "Development of different phenotypes of hypertensive heart failure : Systolic versus diastolic failure in Dahl salt-sensitive rats"J Hypertension. 18. 111-120 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Yamamoto K et al.: "Local neurohumoral Regulation in the Transition to Isolated Diastolic Heart Failure in Hypertensive Heart Disease : Absence of ATI Receptor Downregulation and "Overdrive" of Endothelin system"Cardiovascular Research. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Yamamoto K et al.: "Differential regulation of ventricular production of atrial and brain Natriuretic peptides in hypertensive hearts"Circulation. 100. I-224 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Sakata Y. et al.: "Calcineurin plays a key role in development of diastolic heart failure with preserved systolic function in hypertensive rats"Journal of American College of Cardiology. 35. 205 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Nishikawa N. et al.: "Phenotype shift of collagen production and enhanced inhibition of its degradation contribute to development of diastoric heart failure in hypertensive rats"Journal of American College of Cardiology. 35. 205 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Sakata Y. et al.: "Enhanced inhibition of matrix metalloproteinase is key regulatory mechanism of angiotensin II induced ventricular fibrosis in hypertensive heart"Journal of American College of Cardiology. 35. 321 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Doi R, Masuyama T, Yamamoto K, Doi Y, Mano T, Sakata Y, Ono K, Kuzuya T, Hirota S, Koyama T, Miwa T, Hori M: "Development of different phenotypes of hypertensive heart failure : Systolic versus diastolic failure in Dahl salt-sensitive rats."J Hypertens. 18. 111-120 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Yamamoto K, Masuyama T, Sakata Y, Doi R, Ono K, Mano T, Kondo H, Kuzuya T, Miwa T, Hori M: "Local neurohumoral regulation in the transition to isolated diastolic heart failure in hypertensive heart disease : Absence of AT1 receptor downregulation and "overdrive" of endothelin system."Cardiovasc Res. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Sakata Y, Masuyama T, Yamamoto K, Kondo H, Doi R, Ono K: "Angiotensin II type 1 antagonist prevents transition to isolated diastolic heart failure in hypertensive hearts : Demonstration of roles of renin-angiotensin system."Circulation. 98(17). I-781 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Yamamoto K, Masuyama T, Sakata Y, Doi R, Ono K, Kondo H, Kuzuya T, Miwa T: "Absence of down-regulation of Angiotensin II type 1 receptor in isolated diastolic heart failure due to hypertension : Key to benefits of receptor antagosist"J Am Coll Cardiol. 33(Suppl 1). 284A (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Sakata Y, Masuyama T, Yamamoto K, Doi R, Kondo H, Ono K, Kuzuya T, Miwa T, Hori M: "Angiotensin II receptor blockade does not suppress compensatory hypertrophy but prevents excess hypertrophy contribution to transition to heart failure in hypertensive rats"J Am Coll Cardiol. 33(Suppl 1). 284A (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Yamamoto K, Masuyama T, Sakata Y, Kondo H, Ono K, Miwa T, Hori M.: "Differential regulation of ventricular production of atrial and brain natriuretic peptides in hypertensive hearts."Circulation. 100(Suppl I). I-224 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Sakata Y, Masuyama T, Yamamoto K, Kondo H, Nishikawa N, Ono K, Kuzuya T, Miwa T, Hori M.: "Calcineurin plays a key role in development of diastolic heart failure with preserved systolic function in hypertensive rats."J Am Coll Cardiol. 35(Suppl A). 205 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Nishikawa N, Masuyama T, Yamamoto K, Kondo H, Sakata Y, Ono K, Kuzuya T, Miwa T, Hori M.: "Phenotype shift of collagen production and enhanced inhibition of its degradation contribute to development of diastolic heart failure in hypertensive rats."J Am Coll Cardiol. 35(Suppl A). 205 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Sakata Y, Masuyama T, Yamamoto K, Kondo H, Nishikawa N, Ono K, Kuzuya T, Miwa T, Hori M.: "Enhanced inhibition of matrix metalloproteinase is key regulatory mechanism of angiotensin II induced ventricular fibrosis in hypertensive heart."J Am Coll Cardiol. 35(Suppl A). 321 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Doi R.et al.: "Development of different phenotypes of hypertensive heart failure: Systolic versus diastolic failure in Dahl salt-sensitive rats"J Hypertension. 18. 111-120 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Yamamoto K.et al.: "Local Neurohumoral Regulation in the Transition to Isolated Diastolic Heart Failure in Hypertensive Heart Disease: Absence of AT1 Receptor Downregulation and "Overdrive" of Endothelin System"Cardiovascular Research. (in press).

    • Related Report
      1999 Annual Research Report
  • [Publications] Yamamoto K.et al.: "Differential regulation of ventricular production of atrial and brain Natriuretic peptides in hypertensive hearts"Circulation. 100. I-224 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Sakata Y.et al.: "Calcineurin plays a key role in development of diastolic heart failure with preserved systolic function in hypertensive rats"Journal of American Collese of Cardiology. 35. 205 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Nishikawa N.et al.: "Phenotype shift of collagen production and enhanced inhibition of its degradation contribute to development of diastolic heart failure inhypertensive rats"Journal of American Collese of Cardiology. 35. 205 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Sakata Y.et al.: "Enhanced inhibition of matrix metalloproteinase is key regulatory mechanism of angiotensin II induced ventricular fibrosis in hypertensive heart"Journal of American Collese of Cardiology. 35. 321 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Yasushi Sakata et al.: "Angiotensin II type I antagonist prevents transition to isolated:diastolic heart failure in hypertensive hearts-demonstrati of role of renin angiotensin system." Circulation. 98(17). I-781- (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Kazuhiro Yamamoto et al.: "Absence of down-regulation of angiotensin II type1 receptor in isolated diastolic heart failure due to hypertension:key to benefits of receptor antagonist." Journal of American Collage of Cardiology. in press.

    • Related Report
      1998 Annual Research Report
  • [Publications] Yasushi Sakata et al.: "Angiotensin II receptor blockade does not suppress compensatory hypertrophy but prevents excess hypertrophy." Journal of American Collage of Cardiology. in press.

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi